And

are now a part of the new and improved

Advertisement

Topic: Pediatric

News | February 11, 2019

MedPharm Ltd. Expands Partnership with Palvella Therapeutics, Inc. for PC Treatment

MedPharm Ltd, is expanding its partnership with Palvella Therapeutics, Inc. MedPharm has employed its formulation expertise to support Palvella’s development of a novel, high-strength rapamycin topical formulation for...

Read More

News | April 19, 2019

Fibrocell to Collaborate with Castle Creek Pharmaceuticals to Develop and Commercialize RDEB Gene Therapy

Fibrocell Science, Inc. has entered into a collaboration agreement with Castle Creek Pharmaceuticals to develop and commercialize Fibrocell’s lead gene therapy candidate, FCX-007, for the treatment of recessive dystrophic...

Read More
The Case That Taught Me | March 2019

The Role of ROAT

Steroid DTH should be considered when an inflammatory skin disease continues to worsen despite use of topical corticosteroid.
Sharon E. Jacob, MD; and Jodie Raffi, BA

Contact Dermatitis (CD) is an inflammatory skin condition caused by reactivity to an extrinsic chemical agent. CD is the fifth most common dermatologic disease in American patients, and worldwide prevalence ranges from 12.5 to 40.6 percent,...

Read Article

News | March 1, 2019

Floodwaters and Climate Change Increase Risks for Dermatologic Disease

As more frequent and intense flooding disasters have occurred in conjunction with progressively rising temperatures, both disaster victims and relief workers have experienced significant dermatologic problems, according to new research...

Read More

News | April 8, 2019

La Roche-Posay to Sponsor a Patient to Visit Thermal Dermatology Center: Accepting Nominations

La Roche-Posay brand is sponsoring a patient to travel to the Thermal Dermatology center in the town of La Roche-Posay, France this fall. With 8,000 visitors per year, a third of whom are children, the La Roche-Posay thermal center is...

Read More

Advertisement

The Latest in Pediatric

Advertisement

View more